Linda Llewelyn

Insider

First SEC filing: July 24, 2019 · Latest: June 3, 2026

On this page

Insider at

0 buys (P) 0 sells (S) Net: $0 + 1 non-open-market transaction below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D	vs now
June 1, 2026	HCAT	F	8,519	$1.37	$11,671	321,132 Direct	-2.58%	Disposed	16.4% (price as of 2026-08-21)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Securities held when first becoming an insider, per SEC Form 3.

Date	Ticker	Security	Shares	Ownership
July 24, 2019	HCAT	Stock Option (Right to Buy)→ Common Stock (260)	260	Direct
July 24, 2019	HCAT	Stock Option (Right to Buy)→ Common Stock (500)	500	Direct
July 24, 2019	HCAT	Stock Option (Right to Buy)→ Common Stock (1,000)	1,000	Direct
July 24, 2019	HCAT	Stock Option (Right to Buy)→ Common Stock (3,750)	3,750	Direct
July 24, 2019	HCAT	Stock Option (Right to Buy)→ Common Stock (19,999)	19,999	Direct
July 24, 2019	HCAT	Stock Option (Right to Buy)→ Common Stock (75,000)	75,000	Direct

Matched by name from proxy statements (DEF 14A) — verify against the filing.

Chief People Officer

Fiscal year	Salary	Bonus	Stock awards	Option awards	Non-equity incentive	Pension change	Other	Total
2024	$373,333	—	$924,666	—	$95,071	—	$16,709	$1,409,780
2023	$307,500	—	$693,019	—	$40,840	—	$16,131	$1,057,490
2020	$250,000	—	$852,750	—	$28,750	—	$9,096	$1,140,596

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.